You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT JAMA
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 218 No. 13, December 27, 1971 TABLE OF CONTENTS
  JAMA
  •  Online Features
  ARTICLES
 This Article
 •References
 •Full text PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Contact me when this article is cited
 Related Content
 •Similar articles in JAMA
 Social Bookmarking
  Add to CiteULike Add to Connotea Add to Del.icio.us Add to Digg Add to Reddit Add to Technorati Add to Twitter What's this?

Psychiatric Side Effects of Levodopa in Man

Frederick K. Goodwin, MD

JAMA. 1971;218(13):1915-1920.

Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

Levodopa is the amino acid precursor of the cathecholamines, dopamine and norepinephrine. Along with serotonin, these catecholamines serve as neurotransmitters in areas of the brain related to psychomotor, vegetative, and emotional functions; thus, it is not surprising that the administration of levodopa is associated with mental changes. The documentation and quantification of these mental effects is particularly important because of the potential for increasing our basic understanding of the relationship between brain amines (particularly dopamine) and psychological states both normal and abnormal. When administered to animals, levodopa has been shown to produce a variety of behavioral effects depending to some extent on the dose and species employed; in general, high doses of levodopa produce alerting, motor activation and increased aggressiveness. These studies have recently been the subject of extensive reviews.1,2

The rationale for the use of levodopa in Parkinsonism is based on evidence that a dopamine deficiency exists in . . . [Full Text PDF of this Article]


Author Affiliations

From the Section on Psychiatry, Laboratory of Clinical Science, National Institute of Mental Health, Bethesda, Md.


Footnotes

Read before the Section on Pharmacology and Therapeutics during the 119th annual convention of the American Medical Association, Chicago, June 22, 1970.

Reprint requests to Bldg 10, Room 45-239, National Institutes of Health, Bethesda, Md 20014.



Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter     What's this?





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1971 American Medical Association. All Rights Reserved.